Adding Sleep Intervention to Traditional Diet and Exercise Approach to Weight Loss
NCT ID: NCT01135342
Last Updated: 2023-02-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
28 participants
INTERVENTIONAL
2009-07-31
2010-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Behavioral Weight Loss and Sleep Health Intervention
NCT07255287
Sleep Plus Eating Routines for Weight Loss
NCT01717352
Behavioral Strategies for Weight Management
NCT00575731
Study to Promote Physical Activity Among Overweight Persons
NCT00313040
Effects of Inhibitory Control Training in Eating Behaviors
NCT03599115
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Diet & Exercise plus Sleep Intervention
Diet and exercise instruction to promote weight loss plus cognitive behavioral therapy for insomnia.
Diet and exercise
Standardized instruction to eat less and exercise more to create an energy balance deficit to promote weight loss (16 classes)
Cognitive Behavioral Therapy
Standardized cognitive behavioral therapy for insomnia (8 classes)
Diet & Exercise plus Passion and Balance
Diet and exercise instruction to promote weight loss plus sessions that are of general interest, but unrelated to diet, exercise, or sleep.
Diet and exercise
Standardized instruction to eat less and exercise more to create an energy balance deficit to promote weight loss (16 classes)
Passion and Balance
Attention-match sessions of general interest, but unrelated to diet, exercise, or sleep (8 sessions)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Diet and exercise
Standardized instruction to eat less and exercise more to create an energy balance deficit to promote weight loss (16 classes)
Cognitive Behavioral Therapy
Standardized cognitive behavioral therapy for insomnia (8 classes)
Passion and Balance
Attention-match sessions of general interest, but unrelated to diet, exercise, or sleep (8 sessions)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age: \> or = 18 years
* Ethnicity and race: All ethnic and racial backgrounds welcome
* The following, which will be measured at the screening clinic visit:
* Body Mass Index: 28-40 (kg/m-squared)
* Chronic Short Sleep: total sleep time \< 6.5 hours, greater than or equal to 4 days per week (determined by 1-week sleep log) for the past 6 months or longer (based on self-report).
* Insomnia: sleep latency and/or wake after sleep onset \> 30 minutes, greater than or equal to 4 days per week, insomnia severity index \> 10, and complaint of at least one negative effect during waking hours (such as fatigue, sleepiness, impaired functioning, mood disturbance) attributed to sleep (as determined by self report).
* Eligible sleep disorder: sleep apnea or upper airway resistance syndrome treated by positive airway therapy for \> or = 3 months resulting in improved sleep.
* Psychiatric disorders that are stable on SSRI, SNRI, or bupropion antidepressant for greater than or equal to 3 months if no anticipated changes in medications to occur during the trial if they are weight stable.
* Planning to be available for clinic visits and for the 8 weeks of study participation
* Ability and willingness to give written informed consent.
Exclusion Criteria
* Any suspected sleep disorders identified by the Global Sleep Assessment Questionnaire, including circadian rhythm disorders (including shift work), parasomnias, narcolepsy, and restless leg.
* Self reported personal history of:
* DSM-IV Axis-I and Axis-II diagnoses (i.e. eating disorders, bi-polar disorder, schizophrenia and other psychotic disorders, substance-related disorders, personality disorders, poorly controlled major depression and anxiety disorders determined by SCID) except those allowed under Inclusions.
* Subjects currently receiving the following medications known to affect sleep(self report):
* sedative hypnotics
* sedative antidepressants
* systemic steroids
* anticonvulsants
* histamine-1
* receptor antagonists
* narcotic analgesics
* CNS stimulants
* Body Mass Index (BMI) greater than 40.
* Pregnant, Lactating, or \<6 months post-partum.
* Inability to communicate effectively with study personnel.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Heart, Lung, and Blood Institute (NHLBI)
NIH
Stanford University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Christopher Gardner
Professor of Medicine (Research)
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Christopher D Gardner
Role: PRINCIPAL_INVESTIGATOR
Stanford University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Stanford University School of Medicine
Stanford, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Study description and summary of results.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SU-05062010-5883
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.